Phase I studies of BI 1015550, a preferential phosphodiesterase 4B inhibitor, in heal... | RTCL.TV
Channel: Medicine RTCL TV
Date: 2023-09-21

### Keywords ###
#PulmonaryFibrosis #IdiopathicPulmonary #antifibroticproperties #healthymale #malesubjects #IPF #Fibrosis #RTCLTV #shorts

### Article Attribution ###
Title: Phase I studies of BI 1015550, a preferential phosphodiesterase 4B inhibitor, in healthy males and patients with idiopathic pulmonary fibrosis
Authors: Toby M. Maher, Christina Schlecker, Doreen Luedtke, Sebastian Bossert, Donald F. Zoz ,and Armin Schultz
Publisher: European Respiratory Society
DOI: 10.1183/23120541.00240-2022
DOAJ URL: https://doaj.org/article/21b9b0816508498c90339a882a036afe
Source URL: http://openres.ersjournals.com/content/8/4/00240-2022.full



### Image Attribution ###
We used stable diffusion to programmatically generate the background images. 
Viewer discretion is advised.

### Channels ###
YouTube Channel: https://www.youtube.com/@medicinertcltv
Odysee Channel: https://odysee.com/@medicine_rtcl_tv

### Video Timestamps ###
0:00:00 - Summary 
0:00:28 - Title 
0:00:34 - End